| ISIN | CH0461413913 |
|---|---|
| Valor Number | 46141391 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom FA GBP |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
| Peculiarities |
| Current Price * | 139.43 GBP | 31.10.2025 |
|---|---|---|
| Previous Price * | 140.08 GBP | 30.10.2025 |
| 52 Week High * | 140.08 GBP | 30.10.2025 |
| 52 Week Low * | 108.54 GBP | 09.04.2025 |
| NAV * | 139.43 GBP | 31.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 95,591,340 | |
| Unit/Share Assets *** | 5,304,280 | |
| Trading Information SIX | ||
| YTD Performance | +22.14% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +13.92% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
| 1 month | +4.16% |
30.09.2025 - 31.10.2025
30.09.2025 31.10.2025 |
| 3 months | +7.47% |
31.07.2025 - 31.10.2025
31.07.2025 31.10.2025 |
| 6 months | +15.81% |
30.04.2025 - 31.10.2025
30.04.2025 31.10.2025 |
| 1 year | +23.58% |
31.10.2024 - 31.10.2025
31.10.2024 31.10.2025 |
| 2 years | +41.54% |
31.10.2023 - 31.10.2025
31.10.2023 31.10.2025 |
| 3 years | +51.25% |
31.10.2022 - 31.10.2025
31.10.2022 31.10.2025 |
| 5 years | +110.08% |
02.11.2020 - 31.10.2025
02.11.2020 31.10.2025 |
| Equity Participation Rate in % | 98.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HSBC Holdings PLC | 8.47% | |
|---|---|---|
| AstraZeneca PLC | 8.05% | |
| Shell PLC | 7.24% | |
| Unilever PLC | 5.01% | |
| Rolls-Royce Holdings PLC | 4.67% | |
| British American Tobacco PLC | 3.82% | |
| BP PLC | 3.14% | |
| RELX PLC | 3.03% | |
| GSK PLC | 2.99% | |
| BAE Systems PLC | 2.88% | |
| Last data update | 30.09.2025 | |
| TER | 0.20% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.40% |
| Ongoing Charges *** | 0.20% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |